“INVESTIGATING LONG-TERM SIDE EFFECTS OF SNRI: VENLAFAXINE, DULOXETINE, DESVENLAFAXINE, MILNACIPRAN, AND LEVOMILNACIPRAN ANTIDEPRESSANTS TREATMENT IN PATIENTS DIAGNOSED WITH DEPRESSION” (2026) International Journal of Innovative Technologies in Social Science, 2(1(49). doi:10.31435/ijitss.1(49).2026.4659.